Ownership

Neil Kumar - Chief Executive Officer, Director at BridgeBio Pharma, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: BBIO on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Neil Kumar - trading volume in the past year for BridgeBio Pharma, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-54.8K	100%	$23.55	-$1.29M
Net	-54.8K	-100%		-$1.29M

Holdings reported by Neil Kumar for BridgeBio Pharma, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	4.9M	$111M	$22.76	Nov 19, 2024	Direct
Common Stock	1.01M	$23.1M	$22.76	Nov 19, 2024	By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Common Stock	996K	$22.7M	$22.76	Nov 19, 2024	By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Restricted Stock Units	255K	$6.04M	$23.72	Nov 16, 2024	Direct	Common Stock
Stock Option (right to buy)	45.1K			Mar 12, 2024	Direct	Common Stock

Transactions reported by Neil Kumar for BridgeBio Pharma, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.